Turning Point Therapeutics, Inc. (39) | Consulting Agreements (2)
- Transition Separation and Consulting Agreement, dated January 9, 2020, by and between Jingrong Jean Cui, Ph.D. and Turning Point Therapeutics, Inc (Filed With SEC on January 9, 2020)
- Consulting Agreement by and between the Registrant and Sheila K. Gujrathi, M.D. dated as of November 14, 2017 (Filed With SEC on March 21, 2019)
